COO רווח נקי למניה (EPS TTM) CooperSurgical

Based on management's competence in maintaining a duopoly and increasing margins, the annual net income per share trend reflects the actual business dynamics, where the value 2.96 captures this metric. The Cooper Companies (COO) revenues are based on consumer spending and the certification of new devices. Stable demand from ophthalmologists offsets risks associated with raw material supply disruptions and component logistics.

The non-cyclical demand for ophthalmology solutions from The Cooper Companies (COO) ensures stable dynamics on the rolling annual EPS chart. This indicator is calculated as the ratio of net income over the last 12 months to the number of shares outstanding, excluding paper revaluations and demonstrating the business's actual ability to generate cash flow per share of capital.